Join Accenture in this discussion about how global tariff tensions and evolving FDA challenges
Presented by Accenture
From Disruption to Agility: Resilient Strategies for Medtech in a Shifting Global Order
July 10, 2025 10:30 AM – 11:30 PM ET
From Disruption to Agility: Resilient Strategies for Medtech in a Shifting Global Order
July 10, 2025 10:30 AM – 11:30 PM ET
Join Accenture in this discussion about how global tariff tensions and evolving FDA challenges—exacerbated by Department of Government Efficiency (DoGE) cost-cutting initiatives—are creating significant uncertainty for the MedTech industry. Steep U.S. tariffs have sparked reciprocal measures from other nations, heightening the risk of a costly global trade war and business disruption. Simultaneously, the FDA’s internal reforms and resource constraints are intensifying market access and compliance hurdles. While recent signs of trade de-escalation offer some relief, the potential for sustained or escalating tariffs remains high, placing additional pressure on MedTech manufacturers—especially those producing high-tech and commoditized devices.
This session will explore agile strategies MedTech companies can adopt to navigate these dual regulatory and trade risks, while enhancing operational resilience in a volatile global environment.
Date: July 10, 2025
Time: 10:30 AM -11:30 AM ET
Location: Online
RSVP now to stay ahead of the curve and uncover what’s next for MedTech in today’s dynamic healthcare landscape.
Meet The Speakers
Thomas Kawalec – Global MedTech Industry Lead
Tom Kawalec is Accenture’s Global MedTech Lead for Life Sciences, focusing on strategy, innovation, and people development. With 30+ years of consulting experience, he specializes in Enterprise Reinvention, New Business Models, and Digital Products and Services for large-scale Healthcare companies. Tom is passionate about expediting innovative medical technology and pharmaceutical products to market, while improving healthcare experiences through digital. He is based in Chicago, Illinois.
Oliver Richards – Global MedTech Strategy and Commercialization Lead
Oliver Richards leads Strategy and Commercialization for Accenture Life Sciences Medical Technology. With a Ph.D. in Cell and Molecular Biology and over 15 years of experience in R&D, strategy, and consulting, he specializes in designing and implementing innovative growth strategies for the MedTech market. His expertise spans various areas, including general and orthopedic surgery, cardiovascular and diabetes, in vitro and imaging diagnostics, and digital health. Oliver is based in Milwaukee, Wisconsin.
Garima Mishra – Global MedTech Research Lead
Garima is the Global MedTech Research Lead for Accenture Life Sciences, where she spearheads the development of the firm’s strategic thought leadership for the rapidly evolving MedTech industry. At the forefront of innovation, she leads cutting-edge research on digital health transformation, emerging technologies, consumer-driven healthcare, and disruptive market forces. Her insights help shape how MedTech companies navigate complexity, drive growth, and redefine the future of healthcare delivery. She is based in Bangalore, India.
Ted Fuhr – Vice Chair, Life Sciences
Ted is a Vice Chair for Life Sciences within Accenture’s Reinvention Executive Council. He has over 25 years of experience as both a consultant and executive leader in the industry. Ted has extensive experience in driving an enterprise-wide transformation programs including portfolio and network strategies, margin expansion (price and cost), product and service launches, mergers, divestitures, and large-scale market entries.
Brian Williams – Managing Director
Brian Williams is a member of Accenture’s Global MedTech practice and serves as the Client Account Lead for two of the firm’s key MedTech clients. In addition to serving as the Chief Digital Officer of a Fortune 500 company, Brian has 25 years of experience advising senior executives at the world’s largest Biopharma and MedTech companies. His consulting experience focused on growth strategy, market and product innovation and digital integration and enablement. Brian is based in Indianapolis, Indiana.
Tom Stuart – Global Diagnostics Strategy Lead
Tom Stuart is part of Accenture’s North American Corporate Strategy & Growth and MedTech Practices, where he leads the MedTech Diagnostics Center of Excellence. Tom leverages his technical and commercial strategy background to support MedTech and Diagnostic clients. Tom has significant expertise driving strategic growth initiatives from R&D and product development to pricing & commercial execution to market expansion.
Hear From Us
Sign up to receive emails highlighting our upcoming events, early registration savings, and engagement opportunities for the medical technology community.